In humans, mutations of CAPN3 were shown to be responsible for muscular dystrophy by forward genetics [4], and an intron polymorphism of CAPN10 was reported to be associated with type 2 diabetes by statistical genetics [3]. This evidence concerns the gene CAPN3 and type 2 diabetes mellitus.